The latest episode of Lung Cancer Considered focuses on the IASLC Pathology Committee's creation of the Immunohistochemistry (IHC) Atlas. This episode features a conversation between host Dr. Sanja Dacic, a professor in the department of pathology at the University of Pittsburg Medical Center in Pennsylvania; Dr. Keith Kerr, professor of pulmonary pathology at Aberdeen University Medical School and a consultant pathologist at the Aberdeen Royal Infirmary in Scotland; and Dr. Yasushi Yatabe, chief of the department of diagnostic pathology at the National Cancer Center in Toyko, Japan.

The latest episode of Lung Cancer Considered focuses on a recent article in the IASLC Lung Cancer News publication about the pros and cons of telemedicine. This episode features a conversation between host Dr. Jack West and Dr. Mary Jo Fidler, associate professor of medical oncology at Rush Medical University Center in Chicago and Dr. Sandip Patel, associate professor of medical oncology at the University of California at San Diego.

The latest episode of Lung Cancer Considered focuses on the research from the ADAURA trial that came out of ASCO 2020. This episode features a conversation between IASLC Chief Science Officer, Dr. Chandra Belani; Dr. Nathan Pennell, professor of medicine and director of the Lung Cancer Medical Oncology Program at the Cleveland Clinic Taussig Cancer Institute; Dr. Jack West, an associate clinical professor in medical oncology, a specialist in thoracic oncology and executive director of employee services at City of Hope of Comprehensive Cancer Center; and Jill Feldman, lung cancer patient, patient advocate and co-founder of the group EGFRResisters.

The latest episode of Lung Cancer Considered focuses on a recent publication in IASLC's Journal of Thoracic Oncology that features new guidelines on Tumor Mutational Burden as well as the effects of COVID-19. This episode features a conversation between host Dr. Marty Edelman; Dr. Lynette Scholl an associate professor of Pathology at Harvard Medical School and an associate pathologist, Pathology at Brigham And Women's Hospital; and Dr. John Longshore director of Molecular Pathology at Carolinas Pathology Group, Atrium Health, Carolinas HealthCare System.

The latest episode of Lung Cancer Considered focuses on the virtual format of the ASCO Annual meeting, implications for COVID-19 for how scientific and educational conferences will be structured and the power of social media during a pandemic. This episode features a conversation between host Dr. Jack West and Dr. Tatiana Prowell, associate professor of oncology in the breast cancer program at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Under Armour Breast Health Innovation Center and breast cancer scientific liaison at the U.S. Food and Drug Administration.

The latest episode of Lung Cancer Considered is a post- AACR debrief focusing on MET testing, TERAVOLT data and life in NYC during COVID-19. This episode features a conversation between host Dr. Jack West and Dr. Greg Riely, vice chair of clinical research in the department of medicine at Memorial Sloan Kettering Cancer Center in New York.

The latest episode of Lung Cancer Considered focuses on lung cancer research presented at the American Society of Clinical Oncology virtual meeting this past weekend. This episode features a conversation between IASLC Chief Science Officer, Dr. Chandra Belani and Dr. Stephen Liu, associate professor at the Lombardi Cancer Center at Georgetown University School of Medicine.

The latest episode of Lung Cancer Considered features a conversation between host Dr. Jack West and Dr. Corinne Faivre-Finn, professor of thoracic radiation oncology and honorary consultant clinical oncologist at the Christie National Health Service Foundation Trust in the United Kingdom and Dr. Walter J. Curran, Jr., executive director of the Winship Cancer Institute of Emory University and the Lawrence W. Davis professor and chairman of the Emory Department of Radiation Oncology. The podcast focuses on radiation oncology, lung cancer and COVID-19.

The newest episode of Lung Cancer Considered, the IASLC's official podcast program, features patient advocates and lung cancer researchers on what patients need to know about lung cancer research in the era of COVID-19. This episode features a conversation between Janet Freeman-Daily, writer, lung cancer patient, advocate and Twitter chat moderator of the Lung Cancer Social Media chat (#LCSMchat); Jill Feldman, lung cancer advocate and patient; Dr. Alice Berger, assistant professor of human biology at the Fred Hutchinson Cancer Research Center; Dr. Christine Lovly, associate professor of medicine, division of Hematology and Oncology and Ingram Associate Professor of Cancer Research at Vanderbilt University Medical Center; Dr. Brendon Stiles, associate professor of cardiothoracic surgery at Weill Cornell Medical College, Cornell University, and the associate attending cardiothoracic surgeon at New York Presbyterian Hospital; Dr. Amy Moore has experience as a cancer researcher as director of science and research at the GO2 Foundation for Lung Cancer; Dr Upal Basu Roy also has experience as a cancer researcher as vice president of research at LUNGevity Foundation; and Dr Jan Baranski, vice president of scientific and patient programs for the Lung Cancer Research Foundation.

The newest episode of Lung Cancer Considered, the IASLC's official podcast program, focuses on a discussion between lung cancer experts from the U.S. and Europe discussing COVID-19 with regard to lung cancer patients with experiences, results and actions from different parts of the world. This episode features a conversation between Dr. Marty Edelman, chair of department of hematology/oncology and a professor, department of hematology/oncology at Fox Chase Cancer Center; Dr. Leora Horn, Ingram associate professor of cancer research at Vanderbilt Ingram Cancer Center and clinical director, thoracic oncology program; and Dr. Solange Peters, professor and chair of thoracic oncology at the University of Hospital Lausanne (CHUV), and current president of ESMO.